Recent advances in head and neck squamous cell carcinoma - A review
dc.contributor.author | Safdari, Y | |
dc.contributor.author | Khalili, M | |
dc.contributor.author | Farajnia, S | |
dc.contributor.author | Asgharzadeh, M | |
dc.contributor.author | Yazdani, Y | |
dc.contributor.author | Sadeghi, M | |
dc.date.accessioned | 2018-08-26T07:55:43Z | |
dc.date.available | 2018-08-26T07:55:43Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/48549 | |
dc.description.abstract | The current review presents the results of the most recent studies performed on different aspects of human head and neck squamous cell carcinoma, including radiosensitivity induction, efficiency improvement of monoclonal antibodies using low-intensity ultrasound, chemical compounds such as toll-like receptor (TLC) agonists, dasatinib, resveratrol and niclosamide, nuclear inhibition of cancer using STAT3 decoy oligonucleotide, efficiency of anti-EGFR monoclonal antibodies in detection of head and neck cancers and other related issues. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | CLINICAL BIOCHEMISTRY | |
dc.subject | Head and neck cancer | |
dc.subject | EGFR | |
dc.subject | Apoptosis | |
dc.subject | Radiosensitivity | |
dc.subject | Cetuximab | |
dc.subject | Erlotinib | |
dc.title | Recent advances in head and neck squamous cell carcinoma - A review | |
dc.type | Review | |
dc.citation.volume | 47 | |
dc.citation.issue | 13-14 | |
dc.citation.spage | 1195 | |
dc.citation.epage | 1202 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1016/j.clinbiochem.2014.05.066 |
فایلهای درون آیتم
فایلها | سایز | فرمت | نمایش |
---|---|---|---|
هیچ فایل مرتبطی وجود ندارد |